1. 1014 Using drug dispensing data to assess risk of multiple emergency room visits among cancer patients with comorbidities during their first cancer treatment. (September 2015) Authors: Iwamoto, M.; Nakamura, F.; Higashi, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antioxidant effects of carnitine supplementation on 14-3-3 protein isoforms in the aged rat hippocampus detected using fully automated two-dimensional chip gel electrophoresis. (December 2014) Authors: Iwamoto, M.; Miura, Y.; Tsumoto, H.; Tanaka, Y.; Morisawa, H.; Endo, T.; Toda, T. Journal: Free radical research Issue: Volume 48:Number 12(2014:Dec.) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Catalysts for direct H2O2 synthesis taking advantage of the high H2 activating ability of Pt: kinetic characteristics of Pt catalysts and new additives for improving H2O2 selectivity. Issue 12 (2nd February 2016) Authors: Deguchi, T.; Yamano, H.; Takenouchi, S.; Iwamoto, M. Journal: Catalysis science & technology Issue: Volume 6:Issue 12(2016) Page Start: 4232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhancement of the carrier mobility of conducting polymers by formation of their graphene composites. Issue 20 (20th February 2017) Authors: Chauhan, A. K.; Gupta, S. K.; Taguchi, D.; Manaka, T.; Jha, P.; Veerender, P.; Sridevi, C.; Koiry, S. P.; Gadkari, S. C.; Iwamoto, M. Journal: RSC advances Issue: Volume 7:Issue 20(2017) Page Start: 11913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eribulin improved overall Survival in patients with HER-2 negative metastatic breast cancer–comparison to bevacizumab plus paclitaxel-. (March 2017) Authors: Iwamoto, M.; Kawaguchi, K.; Terasawa, R.; Fujioka, H.; Kimura, K.; Uchiyama, K. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Housing and income effects on HIV-related health outcomes in the San Francisco Bay Area – findings from the SPNS transwomen of color initiative. Issue 11 (2nd November 2018) Authors: Wilson, E. C.; Turner, C.; Arayasirikul, S.; Woods, T.; Nguyen, T.; Lin, R.; Franza, K.; Tryon, J.; Nemoto, T.; Iwamoto, M. Journal: AIDS care Issue: Volume 30:Issue 11(2018) Page Start: 1356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of sentinel lymph nodes using the near infrared light camera system LIGHTVISION. (March 2019) Authors: Iwamoto, M.; Matsutani, A.; Nishida, M.; Hirata, A.; Tominaga, T.; Fujioka, H.; Kimura, K. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P198 Identification of sentinel lymph nodes using the near infrared light camera system LIGHTVISION®. (April 2023) Authors: Iwamoto, M.; Aoki, C.; Ota, M.; Minami, E.; Yoshiyama, A.; Tanaka, M.; Sakane, J.; Ikari, A.; Tominaga, T.; Takai, S.; Oku, H.; Kimura, K.; Lee, S.-W. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P202 Phase 2 study of neoadjuvant anthracycline followed by nab-paclitaxel and trastuzumab. (March 2015) Authors: Iwamoto, M.; Tanaka, S.; Kimura, K.; Matsunami, N.; Morishima, H.; Yoshidome, K.; Nomura, T.; Morimoto, T.; Yamamoto, D.; Tsubota, Y. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II neoadjuvant trial of Albumin-Bound Paclitaxel, Trastuzumab and Pertuzumab followed by anthracycline based regimens in patients with operable Her2 positive breast cancer (OMC-BC05). (April 2021) Authors: Iwamoto, M.; Matsutani, A.; Ikari, A.; Tominaga, T.; Maezawa, S.; Oku, H.; Kimura, K. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗